A Preliminary Study for INFORMED
NCT05585125
Cardiac Failure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT Number: NCT06517186
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
Interested in participating?
Request Info30 year and older
All sexes
Observational
Northwestern University, Chicago, Illinois, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Suspected HFpEF criteria
Exclusion criteria
Time frame: Up to 5 years
Interested in participating?
Request InfoNorthwestern University
Other
Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction (MM-HFpEF) A HeartShare Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05585125
Cardiac Failure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT07214376
Cardiovascular Diseases, Heart Diseases
Houma, Louisiana, United States
View Trial DetailsNCT05064709
Cardiovascular Diseases, Diastolic Heart Failure
Birmingham, Alabama, United States
View Trial DetailsNCT05873634
Cardiovascular Diseases, Heart Diseases
Sacramento, California, United States
View Trial Details